PROSPECTS OF NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER AS A METHOD OF IMPROVING SURVIVAL.

Autor:	Maliarchuk K; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE., Ganul AV; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE., Borisyuk BO; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE., Bororov LV; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE., Shevchenko AI; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE., Sovenko VM; NATIONAL INSTITUTE OF HEALTH PROTECTION OF P.L. SHUPIK ESTATE, KYIV, UKRAINE.
Jazyk:	angličtina
Zdroj:	Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 2022; Vol. 75 (9 pt 1), pp. 2098-2102.
DOI:	10.36740/WLek202209109
Abstrakt:	Objective: The aim: To study the survival rate and count the number of complications in groups with NCRT, NCT and NCT + adjuvant radiotherapy. Patients and Methods: Materials and methods: The studied patients were divided into three groups with a total number of 304 people, Patients who received neoadjuvant chemotherapy-149 people, who received neoadjuvant chemotherapy and adjuvant radiation therapy-90 people. Neoadjuvant chemoradiotherapy was performed in accordance with Cisplatin/Docetaxel or Carboplatin/Paclitaxel 4 Mg and simultaneous radiation therapy with a total radiation dose 30 gray with a single dose of 2 Mg. After neoadjuvant treatment, patients of all groups underwent radical surgery. It consisted of lobectomy, bilobectomy and pneumonectomy. Postoperative complications and the duration of stay in the clinic after surgery were studied. Survival was assessed on the Kaplan and Mayer scale. Results: Results: The study analyzed the main results of treatment, which showed that the 5 years survival in the main group was 28.1±5.9 %, in the control groups-the first control group (neoadjuvant chemotherapy) - 10.4±3.8 % and the second control group (neoadjuvant chemotherapy and adjuvant radiation therapy) - 5.8±2.0 %, respectively. Conclusion: Conclusions: 1. The overall survival rate of patients receiving NCT compared to patients receiving neoadjuvant chemotherapy is higher than in the neoadjuvant chemotherapy group and 13 months higher than in the adjuvant radiation therapy group. 2. Patients who had the phenomenon of a complete morphological response have a significantly higher survival rate (45 and 39 months, respectively).
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu